Opko Health, Inc. (OPK): Shareholders' Equity
$1.27B
As of 2025-12-31
$1.18B
As of 2026-06-30
-6.7%
3-year compound annual growth
-5.4%
5-year compound annual growth
-4.4%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.27B | -7.1% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $1.37B | -1.7% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $1.39B | -11.0% | 2026-02-26, Balance as of period end |
| 2022-12-31 | $1.56B | -7.3% | 2025-03-03, Balance as of period end |
| 2021-12-31 | $1.69B | +0.8% | 2024-03-01, Balance as of period end |
| 2020-12-31 | $1.67B | +3.5% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $1.61B | -9.9% | 2022-03-01, Balance as of period end |
| 2018-12-31 | $1.79B | -2.8% | 2021-02-18, Balance as of period end |
| 2017-12-31 | $1.84B | n/a | 2020-03-02, Balance as of period end |
| No annual figure between 2015-12-31 and 2017-12-31. | |||
| 2015-12-31 | $1.98B | +135.1% | 2016-02-29, Balance as of period end |
| 2014-12-31 | $842.14M | -3.9% | 2016-02-29, Balance as of period end |
| 2013-12-31 | $876.41M | +388.6% | 2015-02-27, Balance as of period end |
| 2012-12-31 | $179.39M | +11.5% | 2014-03-03, Balance as of period end |
| 2011-12-31 | $160.88M | +597.9% | 2013-03-18, Balance as of period end |
| 2010-12-31 | $23.05M | -27.0% | 2013-03-18, Balance as of period end |
| 2009-12-31 | $31.60M | n/a | 2012-03-15, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Opko Health, Inc. (OPK) | 2025-12-31 | $1.27B | -7.1% |
| Insmed Inc (INSM) | 2025-12-31 | $738.98M | +158.9% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $648.02M | +191.4% |
| Axsome Therapeutics, Inc. (AXSM) | 2025-12-31 | $88.30M | +54.9% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $300.13M | +14.2% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $1.25B | +62.1% |
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | -$80.00M | n/m |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $567.61M | +29.5% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $314.69M | +39.5% |
Compare OPK, INSM, TGTX, AXSM side by side · Screen every company in Pharmaceutical Preparations ↗